United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 21, 2026 · Filed Oct 22, 2026

On Oct 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$560.07 for US$5.32M under a trading plan, leaving 324,443 shares. Filed Oct 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$560.07 average (US$552.52 to US$566.43)
Value
US$5.32M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 21, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 21, 2026Common StockSale46US$552.52333,897Indirect
Oct 21, 2026Common StockSale194US$553.78333,703Indirect
Oct 21, 2026Common StockSale550US$555.19333,153Indirect
Oct 21, 2026Common StockSale567US$556.41332,586Indirect
Oct 21, 2026Common StockSale1,702US$557.25330,884Indirect
Oct 21, 2026Common StockSale1,137US$558.32329,747Indirect
Oct 21, 2026Common StockSale743US$559.25329,004Indirect
Oct 21, 2026Common StockSale820US$560.50328,184Indirect
Oct 21, 2026Common StockSale200US$561.44327,984Indirect
Oct 21, 2026Common StockSale960US$562.54327,024Indirect
Oct 21, 2026Common StockSale1,253US$563.43325,771Indirect
Oct 21, 2026Common StockSale768US$564.63325,003Indirect
Oct 21, 2026Common StockSale480US$565.36324,523Indirect
Oct 21, 2026Common StockSale80US$566.43324,443Indirect

Source

Download original · View original at SEC

Related